Skip to main content
. 2020 Jan 21;26(3):353–365. doi: 10.3748/wjg.v26.i3.353

Figure 2.

Figure 2

Our cases with sclerosing cholangitis caused by nivolumab (Case 29, A–C; Case 30, D–F; Case 31, G–J). A, D: Computed tomography; G, H: Magnetic resonance imaging; B, E, I: Endoscopic ultrasonography. Revealed diffuse hypertrophy of biliary tract (yellow allows) in all cases. C, F: Endoscopic retrograde cholangiopancreatography revealed biliary stenosis of the intrahepatic bile duct (arrow-head) in Case 30. J: In Case 31, liver biopsy showed lymphocyte infiltration in Glisson’s capsule (black arrow).